» Articles » PMID: 28614370

The Hemagglutinin-neuramidinase Protein of Newcastle Disease Virus Upregulates Expression of the TRAIL Gene in Murine Natural Killer Cells Through the Activation of Syk and NF-κB

Overview
Journal PLoS One
Date 2017 Jun 15
PMID 28614370
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Newcastle disease virus (NDV) is responsible for tumoricidal activity in vitro and in vivo. However, the mechanisms that lead to this activity are unclear. Natural killer cells are able to induce apoptosis of tumor cells through multiple pathways, including the tumor necrosis factor-related apoptosis-inducing ligand-death receptor pathway. We previously showed that exposure of NK and T cells to NDV resulted in enhanced tumoricidal activity that was mediated by upregulated expression of the TRAIL gene, via an interferon gamma -dependent pathway. Other pathways involved in the upregulated expression of TRAIL are yet to be identified. In the current study, we used mice in which the IFN-γ receptor one gene was inactivated functionally. We identified an IFN-γ-independent TRAIL pathway in the NDV-stimulated NK cells. Hemagglutinin-neuramidinase induced expression of the TRAIL gene in IFN-R1-/- NK cells by binding to the NKp46 receptor. This upregulation was inhibited by pretreatment of NDV with a neutralizing monoclonal antibody against HN, or desialylation of NK cells. Phosphorylation of spleen tryosine kinases and IκBα was increased in HN-induced IFN-R1-/- NK cells. Treatment with the HN neutralizing monoclonal antibody, pharmacological disialylation, or a Syk inhibitor decreased Syk and IκBα phosphorylation levels. We concluded that killer activation receptors pathway is involved in the IFN-γ-independent TRAIL expression of NDV-stimulated NK cells, and these are activated by Syk and NF-κB.

Citing Articles

Immune responses elicited by ssRNA(-) oncolytic viruses in the host and in the tumor microenvironment.

Bykov Y, Dawodu G, Javaheri A, Garcia-Sastre A, Cuadrado-Castano S J Cancer Metastasis Treat. 2023; 9.

PMID: 37974615 PMC: 10653360. DOI: 10.20517/2394-4722.2022.92.


Transcriptome Analysis of Natural Killer Cells in Response to Newcastle Disease Virus Infected Hepatocellular Carcinoma Cells.

Huang J, Zheng T, Liang Y, Qin Y, Wu X, Fan X Genes (Basel). 2023; 14(4).

PMID: 37107646 PMC: 10138298. DOI: 10.3390/genes14040888.


Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy.

Schirrmacher V, Van Gool S, Stuecker W Int J Mol Sci. 2022; 23(21).

PMID: 36361831 PMC: 9655431. DOI: 10.3390/ijms232113050.


Molecular Mechanisms of Anti-Neoplastic and Immune Stimulatory Properties of Oncolytic Newcastle Disease Virus.

Schirrmacher V Biomedicines. 2022; 10(3).

PMID: 35327364 PMC: 8945571. DOI: 10.3390/biomedicines10030562.


Recombinant virus expressing hIFN-λ1 (rL-hIFN-λ1) has important effects on endoplasmic reticulum stress, autophagy and apoptosis in small cell lung cancer.

Yan Y, Shao X, Gu W, Zhang A, Bu X, Liang B Transl Cancer Res. 2022; 9(9):5209-5217.

PMID: 35117888 PMC: 8797832. DOI: 10.21037/tcr-20-1205.


References
1.
Brando C, Mukhopadhyay S, Kovacs E, Medina R, Patel P, Catina T . Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104. J Leukoc Biol. 2005; 78(2):359-71. DOI: 10.1189/jlb.0604360. View

2.
Vigil A, Martinez O, Chua M, Garcia-Sastre A . Recombinant Newcastle disease virus as a vaccine vector for cancer therapy. Mol Ther. 2008; 16(11):1883-90. PMC: 2878970. DOI: 10.1038/mt.2008.181. View

3.
Paulson J, Weinstein J, Dorland L, van Halbeek H, Vliegenthart J . Newcastle disease virus contains a linkage-specific glycoprotein sialidase. Application to the localization of sialic acid residues in N-linked oligosaccharides of alpha 1-acid glycoprotein. J Biol Chem. 1982; 257(21):12734-8. View

4.
Mao H, Tu W, Liu Y, Qin G, Zheng J, Chan P . Inhibition of human natural killer cell activity by influenza virions and hemagglutinin. J Virol. 2010; 84(9):4148-57. PMC: 2863726. DOI: 10.1128/JVI.02340-09. View

5.
Plante M, Arscott W, Folsom J, Tighe S, Dempsey R, Wesley U . Ethanol promotes cytotoxic effects of tumor necrosis factor-related apoptosis-inducing ligand through induction of reactive oxygen species in prostate cancer cells. Prostate Cancer Prostatic Dis. 2012; 16(1):16-22. DOI: 10.1038/pcan.2012.37. View